File PDF .it

Condividi facilmente i tuoi documenti PDF con i tuoi contatti, il Web e i Social network.

Inviare un file File manager Cassetta degli attrezzi Ricerca PDF Assistenza Contattaci



2019 2022 roadmap en.pdf


Anteprima del file PDF 2019-2022roadmapen.pdf

Pagina 1 2 3 4 5 6 7 8 9 10

Anteprima testo


ROADMAP ON VACCINATION
Last update: Q3 2019

ACTIONS

9

TIMELINES AND DELIVERABLES
2018

2019

Consider, jointly with stakeholders, in particular with the vaccinemanufacturing industry, which has a key role in meeting these
aims, possibilities for improving EU manufacturing capacity,
ensuring continuity of supply and ensuring diversity of suppliers.

CR 14e

Meeting with the EU
Official Medicines
Control Laboratories
network

Monitor compliance with the obligation of continuous supply
of medicines placed on marketing authorisation holders
(Article 81 of Directive 2001/83/EC) and explore ways to enhance
compliance with that obligation.
CR 14g

Examination whether
this article has been
implemented in full in
national legislation

CR 14h

2022

Joint procurement of
pandemic influenza
vaccine
Framework contracts
signed in March 2019
https://europa.
eu/rapid/middayexpress-28-03-2019.
htm#8

Support the EU Official Medicines Control Laboratories network
and its work to ensure that vaccines placed on the EU market are
of high quality.
CR 14f

Consider facilitating –together with EMA- early dialogue with
developers, national policy-makers and regulators in order to
support the authorisation of innovative vaccines, including for
emerging health threats.

2021

Conference on
improving EU
manufacturing capacity
and ensuring continuity
of supply

CR 14d

Exploit the possibilities of joint procurement of vaccines
or antitoxins to be used in cases of pandemics, unexpected
outbreaks and in case of small vaccine demand (small number of
cases or very specific populations to be covered).

2020

Actions to facilitate early dialogue with developers, national policy-makers and regulators in order to
support the authorisation of innovative vaccines, including for emerging health threats